Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radbod Darabi

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Iscience|December 9, 2024
Single-nucleus transcriptomic analysis reveals the regulatory circuitry of myofiber XBP1 during regenerative myogenesisAniket S Joshi, Micah B Castillo, Meiricris Tomaz da Silva, et al.
Plos One|April 26, 2017
Pax7 remodels the chromatin landscape in skeletal muscle stem cellsKarin C Lilja, Nan Zhang, Alessandro Magli, et al.
Stem Cells (Dayton, Ohio)|April 23, 2013
A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantationRobert W Arpke, Radbod Darabi, Tara L Mader, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftmentTania Incitti, Alessandro Magli, Radbod Darabi, et al.
Plos Genetics|August 18, 2025
The glycosyltransferase POGLUT1 regulates muscle stem cell development and maintenance in miceSoomin Cho, Emilia Servián-Morilla, Victoria Navarro, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
The glycosyltransferase POGLUT1 regulates muscle stem cell development and maintenance in miceSoomin Cho, Emilia Servián-Morilla, Victoria Navarro Garrido, et al.
Nature Communications|March 7, 2013
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cellsAntonio Filareto, Sarah Parker, Radbod Darabi, et al.
Cell Reports|June 29, 2017
PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic ProgenitorsAlessandro Magli, Tania Incitti, James Kiley, et al.
Skeletal Muscle|October 28, 2015
Pax3-induced expansion enables the genetic correction of dystrophic satellite cellsAntonio Filareto, Fabrizio Rinaldi, Robert W Arpke, et al.
Molecular Therapy. Nucleic Acids|August 31, 2023
Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell nicheJose L Ortiz-Vitali, Jianbo Wu, Nasa Xu, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Iscience|December 9, 2024
Single-nucleus transcriptomic analysis reveals the regulatory circuitry of myofiber XBP1 during regenerative myogenesisAniket S Joshi, Micah B Castillo, Meiricris Tomaz da Silva, et al.
Plos One|April 26, 2017
Pax7 remodels the chromatin landscape in skeletal muscle stem cellsKarin C Lilja, Nan Zhang, Alessandro Magli, et al.
Stem Cells (Dayton, Ohio)|April 23, 2013
A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantationRobert W Arpke, Radbod Darabi, Tara L Mader, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftmentTania Incitti, Alessandro Magli, Radbod Darabi, et al.
Plos Genetics|August 18, 2025
The glycosyltransferase POGLUT1 regulates muscle stem cell development and maintenance in miceSoomin Cho, Emilia Servián-Morilla, Victoria Navarro, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
The glycosyltransferase POGLUT1 regulates muscle stem cell development and maintenance in miceSoomin Cho, Emilia Servián-Morilla, Victoria Navarro Garrido, et al.
Nature Communications|March 7, 2013
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cellsAntonio Filareto, Sarah Parker, Radbod Darabi, et al.
Cell Reports|June 29, 2017
PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic ProgenitorsAlessandro Magli, Tania Incitti, James Kiley, et al.
Skeletal Muscle|October 28, 2015
Pax3-induced expansion enables the genetic correction of dystrophic satellite cellsAntonio Filareto, Fabrizio Rinaldi, Robert W Arpke, et al.
Molecular Therapy. Nucleic Acids|August 31, 2023
Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell nicheJose L Ortiz-Vitali, Jianbo Wu, Nasa Xu, et al.
Pageof 6